Advertisement

Topics

ICON Firecrest Company Profile

07:49 EDT 23rd June 2018 | BioPortfolio


News Articles [86 Associated News Articles listed on BioPortfolio]

ICON launches FIRECREST Financial Disclosure to Reduce Administrative Costs and Increase ...

ICON Media ContactOlivia PimentaWeber Shandwick44-207 067 0557OPimenta@webershandwick.com Read more...

ICON launches FIRECREST Financial Disclosure to Reduce Administrative Costs and Increase Regulatory Compliance

ICON plc, (NASDAQ: ICLR) a global provider of drug development and commercialisation solutions and services, today announced the launch of FIRECREST Financial Disclosure, a...

BancorpSouth Bank To Acquire Icon Capital Corporation In Houston, Texas

Icon operates seven (7) full-service banking offices in the Houston, Texasmetropolitan area.  As of March 31, 2018(unaudited), Icon, on a consolidated basis, reported Read more...

Recent Research Analysts' Ratings Updates for Icon

Several brokerages have updated their recommendations and price targets on shares of Icon in the last few weeks: 1/24/2018 - Icon was given a new $109.00 price target on by analysts at Mizuho. They no...

ClinicalRM becomes ICON GPHS to rapidly respond to global health crises, says CRO

ClinicalRM â which ICON acquired in 2016 â has become ICON Government and Public Health Solutions (GPHS), providing full-service clinical trial execution and functional services to government, NGOs,...

pSivida acquires Icon, rebrands as EyePoint Pharmaceuticals

pSivida Corp. has acquired the specialty biopharmaceutical company Icon Bioscience Inc. and will rebrand as EyePoint Pharmaceuticals, according to pSivida CEO Nancy Lurker, who spoke with Healio.com/O...

Analysts' Recent Ratings Updates for Icon

They now have a $131.00 price target on the stock. 2/15/2018 - Icon had its "neutral" rating reaffirmed by analysts at Mizuho.

Icon and Saama partner to advance RWE use

Saama Technologies and Icon plc are partnering to accelerate the use of real-world evidence (RWE) and improve commercial decision making.

Drugs and Medications [44 Associated Drugs and Medications listed on BioPortfolio]

Bacitracin zinc and polymyxin b sulfate [Bausch & Lomb Incorporated]

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP (Sterile)

Tropicamide [Bausch & Lomb Incorporated]

Tropicamide Ophthalmic Solution USP (Sterile)

Murocel [Bausch & Lomb Incorporated]

Drug Facts

Eye allergy relief [Target Corporation]

Drug Facts

Eye allergy relief [CVS Pharmacy]

Drug Facts

PubMed Articles [16 Associated PubMed Articles listed on BioPortfolio]

Translation and validation study of the Chinese version of the Iconographical Falls Efficacy Scale-Short Version (Icon-FES).

The 30-item Iconographical Falls Efficacy Scale (Icon-FES) is the first instrument developed to assess older people's concern about falling using pictures. The short version of Icon-FES (10-item Icon-...

A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD.

This phase 1 study evaluated the safety and tolerability of single intravitreous injections (IVIs) of ICON-1 (Iconic Therapeutics, South San Francisco, CA) in patients with neovascular age-related mac...

Icon arrays help younger children's proportional reasoning.

We investigated the effects of two context variables, presentation format (icon arrays or numerical frequencies) and time limitation (limited or unlimited time), on the proportional reasoning abilitie...

Randomized Cross-over Comparison of Icon™ Reusable Underwear to Disposable Pads for the Management of Mild to Moderate Urinary Incontinence.

The objective of this study was to compare disposable pads to Icon™ reusable underwear for the management of urinary incontinence on dimensions of quality of life and product performance.

Auditory Icon Alarms Are More Accurately and Quickly Identified than Current Standard Melodic Alarms in a Simulated Clinical Setting.

Current standard audible medical alarms are difficult to learn and distinguish from one another. Auditory icons represent a new type of alarm that has been shown to be easier to learn and identify in ...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances

The aim of this study is to determine the effect of ICON on White spot lesions compared to CPP-ACPF plus.

Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to evaluate the safety and effects of repeated intravitreal injections of ICON-1 0.6 mg administered as maintenance therapy or in combination with aflibercept ...

Randomized Controlled Crossover Comparison of Icon Underwear to Disposable Pads

This is a randomized cross over trial to compare quality of life and product performance between Icon reusable underwear versus standard disposable pad in patients with mild to moderate ur...

Non-invasive Monitor in Endoscopic Invasive Procedure

We include the patients who need painless invasive endoscopic precedure, we collect the dempgraphic data and apply the non-invasive device ICON on patients during the who procedure.

Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation

The aim of the study is to investigate the use of a new FDA-approved non-invasive bio-impedance cardiac monitor, ICON, to detect hemodynamic effects during sedation in children undergoing ...

Companies [27 Associated Companies listed on BioPortfolio]

ICON Firecrest

ICON Clinical Research

ICON was founded in 1990 by a group of experienced professionals, who were dedicated to providing the pharmaceutical and biotechnology industries with exceptional clinical research and biometric servi...

ICON Eyecare

ICON Eyecare is a leading surgical and medical eye care provider, based out of Denver, CO. Since 1999, ICON has been building a Center of Ophthalmology Excellence empowered by an ...

ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic devel...

ICON plc.

ICON plc. is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic deve...

More Information about "ICON Firecrest" on BioPortfolio

We have published hundreds of ICON Firecrest news stories on BioPortfolio along with dozens of ICON Firecrest Clinical Trials and PubMed Articles about ICON Firecrest for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ICON Firecrest Companies in our database. You can also find out about relevant ICON Firecrest Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record